Myobloc FDA Approval History
FDA Approved: Yes (First approved December 8, 2000)
Brand name: Myobloc
Generic name: rimabotulinumtoxinB
Dosage form: Injection
Company: Supernus Pharmaceuticals, Inc.
Treatment for: Cervical Dystonia, Sialorrhea
Last updated by Judith Stewart, BPharm on Jan 23, 2020.
Myobloc (rimabotulinumtoxinB) is an acetylcholine release inhibitor indicated for the treatment of cervical dystonia and chronic sialorrhea.
Development timeline for Myobloc
| Date | Article |
|---|---|
| Aug 26, 2019 | Approval FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.